A European Medicines Agency committee, on Thursday, accepted the use of an artificial intelligence (AI) tool called AIM-NASH ...

The START Center for Cancer Research ("START"), a global leader in early-phase oncology clinical trials, announces the expansion of its network with the acquisition of Carolina Urologic Research ...

Incyte (Nasdaq: INCY) today announced positive topline results from its pivotal Phase 3 STOP-HS clinical trial program evaluating the safety and efficacy of povorcitinib (INCB054707), an oral ...

Investing.com -- Shares of Incyte Corporation (NASDAQ: INCY) fell 14% after the biopharmaceutical company announced topline results from two Phase 3 clinical trials of povorcitinib in patients with ...

Led by Singapore, a 12-year, international, multi-centre, phase 3 clinical trial of aspirin for the secondary prevention of colorectal cancer in over 1,500 patients has been completed and published in ...

Multiracial growth impacts clinical trials. Explore challenges in race classification, health disparities, and genomic ...

This Perspective outlines evidence on existing platform trials in mental health and discusses key challenges and strategies to overcome barriers in order to maximize the potential of platform trials.

Some factors driving the market growth are personalised medicine advancements, biotechnology investment, regulatory reforms, ...

The first to launch was the ACTT-1 trial, though it didn't have that name when it began at the University of Nebraska Medical ...

IQVIA (NYSE:IQV), a leading global provider of AI-powered analytics, technology solutions and clinical research services to the healthcare and life sc ...